Akero Therapeutics, Inc. AKRO
Set alert
54.65 USD 0.00 0.00%
At close · Dec 9
54.69 +0.04 +0.07%
After hours · Dec 9, 4:00 PM ET
54.52 Day range 54.65
53.69 52-week range 54.83
- YTD
- +96.44%
- 1 year
- +75.67%
- Open
- 54.52
- Prev close
- 54.65
- Mkt cap
- 4.50B
- Vol
- 11.61M
- Avg vol
- 2.29M
- EPS
- -1.94
- P/E
- -29.54
- Div yield
- 0.00%
More statistics
- Low
- 54.52
- High
- 54.65
- Beta
- -0.40
- Inst. own
- 112.47%
- Dividend
- 0.00
Financial health
Altman Z-Score
54.74 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -7.4×
FY 2017 5y median -8.1× FY 2024
P/S 0.0×
FY 2017 5y median 0.0× FY 2024
P/B 2.5×
FY 2017 5y median 3.1× FY 2024
P/FCF -8.1×
FY 2017 5y median -9.2× FY 2024
EV/EBITDA -6.3×
FY 2017 5y median -6.9× FY 2024
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2024
FCF Yield -12.4%
FY 2017 5y median -10.8% FY 2024
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2024
ROE -33.6%
FY 2017 5y median -33.6% FY 2024
ROIC -36.3%
FY 2017 5y median -34.1% FY 2024
ROA -30.5%
FY 2017 5y median -30.5% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2024
Operating Income -65.1%
FY 2017 FY 2024
EPS (diluted) -29.8%
FY 2017 FY 2024
Free Cash Flow -59.0%
FY 2017 FY 2024
Financial Health
Current Ratio 19.4×
FY 2017 5y median 19.4× FY 2024
Quick Ratio 19.4×
FY 2017 5y median 19.4× FY 2024
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 1.2×
FY 2017 5y median 1.5× FY 2024
Interest Coverage -61.1×
FY 2017 5y median -55.8× FY 2024
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31